A facility designed from the ground up with EU-GMP guidelines at heart. With the SOPs to match.

State of the Art EU-GMP facilities

Our Quality Commitment to patients is to provide safe and effective medicinal cannabis products within the European market, which are developed, manufactured, distributed and marketed in compliance with the regulatory requirements and our company values: team work, engagement, vision, respect and integrity.

Quality

Greece’s location, climate and talent pool prove a perfect match to the challenging needs of a top-tier medical cannabis production facility. Thankfully we have them covered.

A match made in heaven

Our core values

High Quality

Ready to begin construction of a state-of-the-art GMP and GACP certified facility, we are committed to producing the highest quality medical cannabis products

Product diversity

From dried flower and activated powder to vapes, sublingual oils and gel capsules, CURITY’s product line can cover a wide range of patient needs.

Low Cost

Using a relentlessly optimized production process, while not sacrificing quality, we can achieve a low cost per gram across the whole range of products. Greece’s climate helps as well!

The numbers

Production Capacity

9 tonnes of dried flower annual production capacity.

Cultivation

8.500 sq.m. of state of the art greenhouse cultivation space

Processing

4.000 sq.m. of GMP certified processing facilities

CURITY Pharma S.A.
467 Mesogeion Ave. & 40 Gounari str.
Agia Paraskevi 15343, Greece
Building B - 2nd floor
Contact
  • P: +30 210 6390267
  • F: +30 210 6014886
  • E: info@curitypharma.com

Click to open a larger map